HEPA

Hepion Pharmaceuticals Inc (HEPA)

US
$ 0.27-16.18%

Price Chart

Key Statistics

Market Cap
$ 4.3M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
977.47K
52W High
$ 0.49
52W Low
$ 0.27
Dividend Yield
0.00%
Beta
1.90

Technicals

50-Day MA
1.5112
200-Day MA
21.9791
52 Week High
0.49
52 Week Low
0.272

About HEPA

Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatment for hepatocellular carcinoma (HCC) and other chronic liver diseases in the United States.

Employees
N/A
Headquarters
Morristown, NJ
CEO
Sharen Pyatetskaya

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Losers

Symbol/Name
LTP
% Chg